Decoy Therapeutics Inc. is trading 10.2% up today at $6.48, reversing a portion of yesterday’s losses tied to dilution concerns from a resale filing.
- The stock faced downward pressure on June 16 after the company registered up to 808,000 common shares for resale under a committed equity financing facility.
- Today's price action appears to be a relief rebound as investors reassess the filing, which had initially sparked fears of approximately 60% dilution.